![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.prnewswire.com/news-releases/sifi-receives-comp-positive-opinion-on-orphan-drug-designation-for-polihexanide-in-treating-fungal-keratitis-302202163.html
https://www.pharmaceutical-technology.com/news/chmp-approves-backing-for-first-acanthamoeba-keratitis-treatment/
https://www.prnewswire.com/news-releases/sifi-receives-positive-chmp-opinion-for-akantior-polihexanide-0-08-in-acanthamoeba-keratitis-302159647.html
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416
https://www.prnewswire.com/news-releases/sifi-reports-detailed-positive-results-and-new-data-from-the-completed-phase-3-trial-of-akantior-in-patients-with-acanthamoeba-keratitis-presented-at-the-american-academy-of-ophthalmology-annual-meeting-in-chicago-301647790.html
https://www.prnewswire.com/news-releases/sifi-announces-positive-topline-results-of-the-pivotal-phase-iii-study-of-polihexanide-for-the-treatment-of-acanthamoeba-keratitis-301402496.html
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-April-24-2019-1556080066.pdf